68 related articles for article (PubMed ID: 30082213)
1. Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis.
Liu J; Zhang H; Xia Y; Yang T; Gao Y; Li J; Wu Y; Shen F
HPB (Oxford); 2019 Jan; 21(1):1-13. PubMed ID: 30082213
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: a systematic review and meta-analysis.
Xiang ZQ; Wu YC; Qu XL; Luo DJ; Liang H; Ameer S; Long ZT; Dai XM; Zhu Z
World J Surg Oncol; 2024 Jan; 22(1):3. PubMed ID: 38166925
[TBL] [Abstract][Full Text] [Related]
3. Prognosis and safety of laparoscopic hepatectomy for BCLC stage 0/A hepatocellular carcinoma with clinically significant portal hypertension: a multicenter, propensity score-matched study.
Xia F; Zhang Q; Ndhlovu E; Zheng J; Yuan M; Gao H; Xia G
Surg Endosc; 2024 Feb; 38(2):799-812. PubMed ID: 38062182
[TBL] [Abstract][Full Text] [Related]
4. Is hepatectomy feasible for hepatocellular carcinoma patients with clinically significant portal hypertension and beyond the Milan criteria?
Lu Z; Wei X; Tan L; Xiang B; Gong W
Eur J Surg Oncol; 2023 Nov; 49(11):107073. PubMed ID: 37748278
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Portal Hypertension Assessment Method on the Outcomes of Hepatocellular Carcinoma Resection: A Meta-Analysis of Matched Cohort and Prospective Studies.
Aliseda D; Zozaya G; Martí-Cruchaga P; Herrero I; Iñarrairaegui M; Argemí J; Martínez De La Cuesta A; Blanco N; Sabatella L; Sangro B; Rotellar F
Ann Surg; 2024 Jul; 280(1):46-55. PubMed ID: 38126757
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of partial hepatectomy for huge (≥10 cm) hepatocellular carcinoma: a systematic review.
Zhou YM; Li B; Xu DH; Yang JM
Med Sci Monit; 2011 Feb; 17(3):RA76-83. PubMed ID: 21358616
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis of outcomes after liver resection in patients with hepatocellular carcinoma (HCC) with and without bile duct thrombus.
Navadgi S; Chang CC; Bartlett A; McCall J; Pandanaboyana S
HPB (Oxford); 2016 Apr; 18(4):312-6. PubMed ID: 27037199
[TBL] [Abstract][Full Text] [Related]
8. Safety of hepatectomy for elderly patients with hepatocellular carcinoma.
Oishi K; Itamoto T; Kohashi T; Matsugu Y; Nakahara H; Kitamoto M
World J Gastroenterol; 2014 Nov; 20(41):15028-36. PubMed ID: 25386051
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of preoperative prognostic nutritional index in hepatocellular carcinoma: a meta-analysis.
Man Z; Pang Q; Zhou L; Wang Y; Hu X; Yang S; Jin H; Liu H
HPB (Oxford); 2018 Oct; 20(10):888-895. PubMed ID: 29853431
[TBL] [Abstract][Full Text] [Related]
10. Hepatectomy in hepatocellular carcinoma beyond Milan criteria and portal hypertension - Critical remarks.
Magyar CTJ; Li Z; Banz V; Sapisochin G
Eur J Surg Oncol; 2024 Feb; 50(2):107310. PubMed ID: 38169184
[No Abstract] [Full Text] [Related]
11. Relationship between portal hypertension and liver stiffness measurements in the treatment of hepatocellular carcinoma from the surgeon's point of view in the Baveno VII era.
Takemura N; Kokudo N
Hepatobiliary Surg Nutr; 2024 Feb; 13(1):150-153. PubMed ID: 38322205
[No Abstract] [Full Text] [Related]
12. Management of Portal Hypertension in Patients with Hepatocellular Carcinoma on Systemic Treatment: Current Evidence and Future Perspectives.
De Gaetano V; Pallozzi M; Cerrito L; Santopaolo F; Stella L; Gasbarrini A; Ponziani FR
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611066
[TBL] [Abstract][Full Text] [Related]
13. Impact of the COVID-19 pandemic on the number and short-term outcomes in hepatectomy for hepatocellular carcinoma: Results from the Japanese National Clinical Database, 2018-2021.
Takemura Y; Endo H; Hibi T; Nakano Y; Seishima R; Takeuchi M; Yamamoto H; Maeda H; Hanazaki K; Taketomi A; Kakeji Y; Seto Y; Ueno H; Mori M; Kitagawa Y
Hepatol Res; 2024 Feb; ():. PubMed ID: 38308614
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the ability of Child-Pugh score, MELD score, and ICG-R15 to assess preoperative hepatic functional reserve in patients with hepatocellular carcinoma.
Wang YY; Zhao XH; Ma L; Ye JZ; Wu FX; Tang J; You XM; Xiang BD; Li LQ
J Surg Oncol; 2018 Sep; 118(3):440-445. PubMed ID: 30259515
[TBL] [Abstract][Full Text] [Related]
15. Hepatectomy for hepatocellular carcinoma after perioperative management of portal hypertension.
Takemura N; Aoki T; Hasegawa K; Kaneko J; Arita J; Akamatsu N; Makuuchi M; Kokudo N
Br J Surg; 2019 Jul; 106(8):1066-1074. PubMed ID: 30990885
[TBL] [Abstract][Full Text] [Related]
16. Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study.
Lee MS; Ryoo BY; Hsu CH; Numata K; Stein S; Verret W; Hack SP; Spahn J; Liu B; Abdullah H; Wang Y; He AR; Lee KH;
Lancet Oncol; 2020 Jun; 21(6):808-820. PubMed ID: 32502443
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative Increase of Portal Venous Pressure is an Immediate Predictor of Posthepatectomy Liver Failure After Major Hepatectomy: A Prospective Study.
Bogner A; Reissfelder C; Striebel F; Mehrabi A; Ghamarnejad O; Rahbari M; Weitz J; Rahbari NN
Ann Surg; 2021 Jul; 274(1):e10-e17. PubMed ID: 31356261
[TBL] [Abstract][Full Text] [Related]
18. Synchronous hepatectomy and splenectomy vs hepatectomy for selected patients with hepatocellular carcinoma and clinically significant portal hypertension: A systematic review and meta-analysis.
Kong J; Shen S; Wang W
J Surg Oncol; 2019 Jun; 119(7):964-973. PubMed ID: 30775785
[TBL] [Abstract][Full Text] [Related]
19. Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition).
Zhou J; Sun H; Wang Z; Cong W; Wang J; Zeng M; Zhou W; Bie P; Liu L; Wen T; Han G; Wang M; Liu R; Lu L; Ren Z; Chen M; Zeng Z; Liang P; Liang C; Chen M; Yan F; Wang W; Ji Y; Yun J; Cai D; Chen Y; Cheng W; Cheng S; Dai C; Guo W; Hua B; Huang X; Jia W; Li Y; Li Y; Liang J; Liu T; Lv G; Mao Y; Peng T; Ren W; Shi H; Shi G; Tao K; Wang W; Wang X; Wang Z; Xiang B; Xing B; Xu J; Yang J; Yang J; Yang Y; Yang Y; Ye S; Yin Z; Zhang B; Zhang B; Zhang L; Zhang S; Zhang T; Zhao Y; Zheng H; Zhu J; Zhu K; Liu R; Shi Y; Xiao Y; Dai Z; Teng G; Cai J; Wang W; Cai X; Li Q; Shen F; Qin S; Dong J; Fan J
Liver Cancer; 2020 Dec; 9(6):682-720. PubMed ID: 33442540
[TBL] [Abstract][Full Text] [Related]
20. A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma.
Shi JY; Sun LY; Quan B; Xing H; Li C; Liang L; Pawlik TM; Zhou YH; Wang H; Gu WM; Chen TH; Lau WY; Shen F; Wang NY; Yang T
Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101534. PubMed ID: 33067168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
